Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Cash Flow-to-Debt Ratio
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Cash Flow-to-Debt Ratio of 0.11x as of September 2025, meaning its operating cash flow of CN¥201.83 Million could theoretically repay 0% of its total liabilities (CN¥1.83 Billion) in one year. See 600557 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Kanion Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Jiangsu Kanion Pharmaceutical Co Ltd across 24 annual periods. Also explore 600557 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Year-by-year debt coverage analysis for Jiangsu Kanion Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Jiangsu Kanion Pharmaceutical Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥702.49 Million | CN¥2.20 Billion | ▼ -43.0% |
| 2023 | 0.56x | CN¥972.32 Million | CN¥1.74 Billion | ▲ +4.7% |
| 2022 | 0.53x | CN¥995.94 Million | CN¥1.86 Billion | ▼ -9.0% |
| 2021 | 0.59x | CN¥908.30 Million | CN¥1.55 Billion | ▲ +50.2% |
| 2020 | 0.39x | CN¥701.10 Million | CN¥1.79 Billion | ▼ -14.5% |
| 2019 | 0.46x | CN¥925.73 Million | CN¥2.02 Billion | ▲ +23.0% |
| 2018 | 0.37x | CN¥636.39 Million | CN¥1.71 Billion | ▲ +74.9% |
| 2017 | 0.21x | CN¥382.93 Million | CN¥1.80 Billion | ▲ +8.4% |
| 2016 | 0.20x | CN¥299.02 Million | CN¥1.52 Billion | ▼ -45.4% |
| 2015 | 0.36x | CN¥514.80 Million | CN¥1.43 Billion | ▲ +84.3% |
| 2014 | 0.19x | CN¥311.54 Million | CN¥1.60 Billion | ▼ -24.8% |
| 2013 | 0.26x | CN¥388.11 Million | CN¥1.50 Billion | ▲ +80.1% |
| 2012 | 0.14x | CN¥212.11 Million | CN¥1.47 Billion | ▲ +76.5% |
| 2011 | 0.08x | CN¥90.19 Million | CN¥1.11 Billion | ▼ -63.6% |
| 2010 | 0.22x | CN¥166.40 Million | CN¥743.19 Million | ▲ +476.0% |
| 2009 | -0.06x | CN¥-21.87 Million | CN¥367.23 Million | ▼ -136.3% |
| 2008 | 0.16x | CN¥58.39 Million | CN¥355.85 Million | ▼ -16.2% |
| 2007 | 0.20x | CN¥92.73 Million | CN¥473.81 Million | ▼ -20.4% |
| 2006 | 0.25x | CN¥108.98 Million | CN¥443.19 Million | ▲ +29.1% |
| 2005 | 0.19x | CN¥101.44 Million | CN¥532.62 Million | ▲ +225.8% |
| 2004 | 0.06x | CN¥21.68 Million | CN¥370.88 Million | ▲ +37.8% |
| 2003 | 0.04x | CN¥17.13 Million | CN¥403.56 Million | ▼ -64.7% |
| 2002 | 0.12x | CN¥11.15 Million | CN¥92.69 Million | ▼ -40.7% |
| 2001 | 0.20x | CN¥21.02 Million | CN¥103.61 Million | — |